One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial. (Q50870355)
Jump to navigation
Jump to search
scientific article published in August 1998
Language | Label | Description | Also known as |
---|---|---|---|
English | One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial. |
scientific article published in August 1998 |
Statements
One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial. (English)
1 reference
van der Wouden EJ
1 reference
Thijs JC
1 reference
van Zwet AA
1 reference
Kooy A
1 reference
Kleibeuker JH
1 reference
1 August 1998
1 reference
93
1 reference
8
1 reference
1228-1231
1 reference